MiMedx Group, Inc (MDXG) Stock Price

MDXGStock

$4.34−41.59%52W

Market Cap$632.60M

P/E12.60x

PEG Ratio2.88

Div yield—

Beta1.22

MDXG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-29.45%

Price vs S&P 500 (4W)-5.12%

PEG Ratio2.88

VGM Score48.31

P/E Ratio (Annual)12.60x

P/CF (Annual)8.27x

Book Value / Share (Quarterly)$1.48

P/TBV (Annual)4.14x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)16.06%

Cash Flow / Share (Quarterly)$0.30

Price vs S&P 500 (YTD)-48.89%

Gross Margin (TTM)78.85%

Net Profit Margin (TTM)1.76%

EPS (TTM)$0.04

10-Day Avg Trading Volume1.05M

EPS Excl Extra (TTM)$0.04

Revenue Growth (5Y)11.02%

EPS (Annual)$0.32

ROI (Annual)17.70%

Gross Margin (Annual)82.56%

Net Profit Margin (5Y Avg)5.32%

Cash / Share (Quarterly)$0.93

P/E Basic Excl Extra (TTM)98.12x

Revenue Growth QoQ (YoY)-34.73%

P/E Normalized (Annual)12.60x

ROA (Last FY)14.18%

Revenue Growth TTM (YoY)-2.36%

EBITD / Share (TTM)$0.06

ROE (5Y Avg)6.01%

Operating Margin (TTM)2.46%

Cash Flow / Share (Annual)$0.49

P/B Ratio2.83x

P/B Ratio (Quarterly)2.65x

Net Income / Employee (Annual)$60,100

EV / Revenue (TTM)1.39x

Net Interest Coverage (TTM)77.70x

ROA (TTM)1.99%

EPS Growth QoQ (YoY)103.21%

EV / EBITDA (TTM)51.50x

EPS Incl Extra (Annual)$0.32

Current Ratio (Annual)4.32x

Quick Ratio (Quarterly)4.79x

3-Month Avg Trading Volume1.52M

52-Week Price Return-41.59%

EV / Free Cash Flow (Annual)6.76x

P/E Incl Extra (TTM)98.12x

Revenue / Employee (TTM)$439,600

Tangible BV / Share (Quarterly)$1.40

P/S Ratio (Annual)1.46x

Asset Turnover (Annual)1.22x

52-Week High$7.97

Operating Margin (5Y Avg)6.48%

EPS Excl Extra (Annual)$0.32

CapEx CAGR (5Y)-25.69%

Tangible BV CAGR (5Y)23.20%

26-Week Price Return-18.20%

Quick Ratio (Annual)3.92x

13-Week Price Return18.28%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)5.33x

Enterprise Value$493.56M

Revenue / Share Growth (5Y)4.06%

Asset Turnover (TTM)1.14x

Book Value / Share Growth (5Y)16.02%

Revenue / Employee (Annual)$518,100

Inventory Turnover (Annual)2.97x

Pretax Margin (Annual)15.83%

Cash / Share (Annual)$1.12

3-Month Return Std Dev34.45%

Gross Margin (5Y Avg)82.71%

Net Income / Employee (TTM)$7,700

ROE (Last FY)18.94%

Net Interest Coverage (Annual)8.59x

EPS Basic Excl Extra (Annual)$0.32

P/FCF (TTM)8.83x

Receivables Turnover (TTM)6.43x

EV / Free Cash Flow (TTM)11.11x

Total Debt / Equity (Quarterly)0.08x

EPS Incl Extra (TTM)$0.04

Receivables Turnover (Annual)6.37x

ROI (TTM)2.43%

P/S Ratio (TTM)1.72x

Pretax Margin (5Y Avg)5.34%

Revenue / Share (Annual)$2.80

Tangible BV / Share (Annual)$1.64

Forward P/E32.53x

Price vs S&P 500 (52W)-59.90%

P/E Ratio (TTM)98.12x

EPS Growth TTM (YoY)-81.69%

Year-to-Date Return-36.93%

5-Day Price Return-1.61%

EPS Normalized (Annual)$0.32

ROA (5Y Avg)6.30%

Net Profit Margin (Annual)11.60%

Month-to-Date Return3.39%

Cash Flow / Share (TTM)$0.01

EBITD / Share (Annual)$0.44

Operating Margin (Annual)15.26%

LT Debt / Equity (Annual)0.06x

P/CF (TTM)13.27x

ROI (5Y Avg)7.24%

P/E Excl Extra (TTM)98.12x

LT Debt / Equity (Quarterly)0.07x

EPS Basic Excl Extra (TTM)$0.04

P/TBV (Quarterly)2.81x

P/B Ratio (Annual)3.91x

Inventory Turnover (TTM)3.28x

Pretax Margin (TTM)3.25%

Book Value / Share (Annual)$1.73

Price vs S&P 500 (13W)15.49%

Beta1.22x

P/FCF (Annual)8.39x

Revenue / Share (TTM)$2.40

ROE (TTM)2.61%

52-Week Low$3.03

vGradeC

gGradeD

mGradeC

vgmGradeC

MDXG Earnings Surprise History

Q2 250.10est. 0.06

Q3 250.15est. 0.07

Q4 250.14est. 0.11

Q1 26-0.05est. -0.04

Q2 26-0.05est. -0.03

MDXG Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.08

4.09

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
MDXGMiMedx Group, Inc	C	D	C	$4.34
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16
SIShoulder Innovations, Inc.	—	B	A	$22.32

About MiMedx Group, Inc

MiMedx Group develops regenerative biomaterial products derived from human amniotic membrane and birth tissues for wound care, surgical, burn, orthopedic, and sports medicine applications. The company's core offerings include EpiFix and AmnioFix, flagship allografts that address external and internal wound healing needs across multiple surgical specialties. MiMedx also generates revenue through licensed partnerships for ophthalmic and dental applications.